Cantaloupe, Inc. Files Q3 2024 10-Q

TL;DR

Cantaloupe's Q3 2024 10-Q is in, check the revenue numbers for product & services.

AI Summary

Cantaloupe, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported revenue from contracts with customers, excluding assessed taxes, for both its product and service segments. Specific financial figures for the quarter and year-to-date are detailed within the filing.

Why It Matters

This filing provides investors with the latest financial performance data for Cantaloupe, Inc., crucial for understanding the company's operational health and future prospects.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing with no immediate red flags apparent from the provided header information.

Key Numbers

• 2024-09-30 — Period End Date (Reporting period for the 10-Q)
• 2024-07-01 — Quarter Start Date (Beginning of the reporting quarter)
• 2023-07-01 — Prior Year Quarter Start Date (Beginning of the comparable prior year quarter)

Key Players & Entities

• CANTALOUPE, INC. (company) — Filer
• 20240930 (date) — Period of Report
• 20241107 (date) — Filing Date
• PA (location) — State of Incorporation

FAQ

Filing Documents

• ctlp-20240930.htm (10-Q) — 936KB
• a20240930-exx311.htm (EX-31.1) — 10KB
• a20240930-exx312.htm (EX-31.2) — 10KB
• a20240930-exx321.htm (EX-32.1) — 4KB
• a20240930-exx322.htm (EX-32.2) — 4KB
• ctlp-20240930_g1.jpg (GRAPHIC) — 98KB
• 0001628280-24-046366.txt ( ) — 6321KB
• ctlp-20240930.xsd (EX-101.SCH) — 42KB
• ctlp-20240930_cal.xml (EX-101.CAL) — 103KB
• ctlp-20240930_def.xml (EX-101.DEF) — 160KB
• ctlp-20240930_lab.xml (EX-101.LAB) — 565KB
• ctlp-20240930_pre.xml (EX-101.PRE) — 384KB
• ctlp-20240930_htm.xml (XML) — 889KB

- Financial Information

Part I - Financial Information Item 1. Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets - September 3 0 , 2024 (unaudited) and June 30, 202 4 3 Condensed Consolidated Statements of Operations - Three Months ended September 3 0 , 2024 and 2023 (unaudited) 4 Condensed Consolidated Statements of Comprehensive Income - Three Months ended September 3 0 , 2024 and 2023 (unaudited) 5 Condensed Consolidated Statements of Convertible Preferred Stock and Shareholders' Equity - Three Months ended September 3 0 , 2024 and 2023 (unaudited) 6 Condensed Consolidated Statements of Cash Flows - Three Months ended September 3 0 , 2024 and 2023 (unaudited) 7 Notes to Condensed Consolidated Financial Statements (unaudited) 8 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 21 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 29 4.

Controls and Procedures

Controls and Procedures 30

- Other Information

Part II - Other Information Item 1. Legal Proceedings 31 1A. Risk Factors 31 2. Unregistered Sales of Equity Securities and Use of Proceeds 31 3. Defaults Upon Senior Securities 31 4. Mine Safety Disclosures 31 5. Other Information 31 6. Exhibits 32

Financial Information

Part I. Financial Information

Condensed Consolidated Financial Statements

Item 1. Condensed Consolidated Financial Statements Cantaloupe, Inc. Condensed Consolidated Balance Sheets September 30, 2024 (Unaudited) June 30, 2024 ($ in thousands, except share data) Assets Current assets: Cash and cash equivalents $ 33,124 $ 58,920 Accounts receivable, net 32,490 43,848 Finance receivables, net 6,104 6,391 Inventory 44,571 40,791 Prepaid expenses and other current assets 7,456 7,844 Total current assets 123,745 157,794 Non-current assets: Finance receivables, net 8,873 10,036 Property and equipment, net 35,888 34,029 Operating lease right-of-use assets 8,276 7,986 Intangibles, net 26,762 24,626 Goodwill 102,708 94,903 Other assets 5,883 6,194 Total non-current assets 188,390 177,774 Total assets $ 312,135 $ 335,568 Liabilities, convertible preferred stock, and shareholders' equity Current liabilities: Accounts payable $ 52,612 $ 78,895 Accrued expenses 21,743 24,008 Current obligations under long-term debt 1,362 1,266 Deferred revenue 1,471 1,726 Total current liabilities 77,188 105,895 Long-term liabilities: Deferred income taxes 505 466 Long-term debt, less current portion 35,919 36,284 Other noncurrent liabilities 9,573 8,457 Total long-term liabilities 45,997 45,207 Total liabilities 123,185 151,102 Commitments and contingencies (Note 14) Convertible preferred stock: Series A convertible preferred stock, 900,000 shares authorized, 385,782 and 385,782 issued and outstanding, with liquidation preferences of $ 23,011 and $ 22,722 at September 30, 2024 and June 30, 2024, respectively 2,720 2,720 Shareholders' equity: Common stock, no par value, 640,000,000 shares authorized, 72,986,172 and 72,935,497 shares issued and outstanding at September 30, 2024 and June 30, 2024, respectively — — Additional paid-in capital 483,052 482,329 Accumulated deficit ( 296,887 ) ( 300,459 ) Accumulated other comprehensive income (loss) 65 ( 124 ) Total shareholders' equity 186,230 181,746 Total liabilities

View Full Filing

View this 10-Q filing on SEC EDGAR